These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15879849)

  • 1. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.
    Naslund MJ; Carlson AM; Williams MJ
    J Urol; 2005 Jun; 173(6):2090-3; discussion 2093. PubMed ID: 15879849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
    Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
    Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
    Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing benign prostatic hyperplasia.
    Dull P; Reagan RW; Bahnson RR
    Am Fam Physician; 2002 Jul; 66(1):77-84. PubMed ID: 12126034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.
    Nørby B; Nielsen HV; Frimodt-Møller PC
    Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPH: costs and treatment outcomes.
    Nickel JC
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S141-8. PubMed ID: 16613528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
    Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
    Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM
    BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transurethral ablation (Precision Plus) in the treatment of patients with benign prostatic hyperplasia].
    Mazo EB; Krivoborodov GG
    Urologiia; 2005; (3):12-5. PubMed ID: 16097706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
    Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
    Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical-economic models of benign prostatic hypertrophy].
    Le Pen C; Lukacs B; Rumeau-Pichon C; Bonastre J
    Prog Urol; 1998 Dec; 8(6):961-8. PubMed ID: 9894254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.
    Black L; Naslund MJ; Gilbert TD; Davis EA; Ollendorf DA
    Am J Manag Care; 2006 Mar; 12(4 Suppl):S99-S110. PubMed ID: 16551208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urologic diseases in America project: benign prostatic hyperplasia.
    Wei JT; Calhoun E; Jacobsen SJ
    J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
    Hourriez LA; Zlotta AR; Schulman CC
    Acta Urol Belg; 1994 Dec; 62(4):33-8. PubMed ID: 7540796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.